AAPM VISION. John D. Hazle, Ph.D., FAAPM, FACR

Similar documents
Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program

21ST CENTURY MEDICINE

PHYSICS NEEDS IN RADIATION SCIENCES. James Deye, Ph. D. Contractor, NCI Radiation Research Program

RO-ILS: Radiation Oncology Incident Learning System Congressional Briefing

SKCC Protocol Review Committee New Study Application

Translating Duke Health. Accelerating discovery and its translation

Colorectal Cancer Screening

7/30/2017. One World Medical Physics: Challenges and Opportunities in Cancer Care. Worldwide Demographic Shift

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

Cancer prevalence. Chapter 7

Sustain and Seize Cancer Research Opportunities

London Regional Cancer Program

Making a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:

American Nuclear Society Annual Meeting Chicago, June 24-28, 2012 President s Special Session

Monitoring Patients Undergoing Cancer Therapy. By Timothy K. Egan

Genomic Health. Kim Popovits, Chairman, CEO and President

CLINICAL RESEARCH IN GEORGIA UPDATE. Nancy M. Paris, MS, FACHE President, Georgia CORE September 6, 2014

Health Inequity and Controversies in Cancer Screening. Doris Browne, MD, MPH Immediate Past President, NMA September

Bioengineering and World Health. Lecture Twelve

Stephan Achenbach, FESC

DIET, MEAT, AND CANCER

CANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients

Washington, DC Washington, DC Washington, DC Washington, DC 20510

History of Oncology Research at Intermountain Healthcare

Oncology 101. Cancer Basics

OVAC FY 2017 Appropriations Requests

Cancer Research in the EU Framework Programmes for RTD

Diversity Clinical Research Workshop Invited Faculty

DATAWATCH 121. Increasing The Odds For Cancer Survival

The National Academies

Burden of Cancer in California

Building a healthier tomorrow: The power of prevention to create a world with more birthdays

BACK TO SPINAL RESEARCH

A World Free From Cancer. BC Cancer Foundation 2011 Report to Donors

Epidemiology in Texas 2006 Annual Report. Cancer

Testimony of Robert Egge, Vice President of Public Policy Alzheimer s Association. December 8, 2010

GPS Cancer. For Health Plans and Employers. Precise molecular profiling for informed, personalized cancer treatment strategies MOLECULAR PROFILING

Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials

FAMILY MATTERS IN WALDENSTROM MACROGLOBULINEMIA by Mary McMaster, MD

Saskatchewan Cancer Control Report. Profiling Cancer in Regional Health Authorities

Achieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016

Evaluations. Dementia Update: A New National Plan for Alzheimer s Disease Research, Care and Services. Disclosure Statements.

Re: NOT-DK ; Request for Information (RFI): Soliciting Input on the Draft Strategic Plan for NIH Nutrition Research

TOLUCA, ESTADO DE MEXICO, MEXICO. OCTOBER

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer

Murtha Cancer Center The DoD Cancer Center of Excellence

Outcomes Report: Accountability Measures and Quality Improvements

Second Neoplasms Working Group. CCSS Investigators Meeting June 2017

Lung Cancer Screening In High Risk Populations:

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

Overview of 2010 Hong Kong Cancer Statistics

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012

The Hallmarks of Cancer

Ludwig Presence at 2016 ASCO Annual Meeting

Highlights from AACR 2015: The Emerging Potential of Immunotherapeutic Approaches in Non-Small Cell Lung Cancer

Outline. NCRP Scientific Committee 6-2

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014

Defeating Colon Cancer with Surgery

Molecular Imaging and Cancer

Medical Dosimetry Graduate Certificate Program IU Graduate School & The Department of Radiation Oncology IU Simon Cancer Center

Oregon Health Plan Guideline Note 12

Annual Report to the Nation on the Status of Cancer, , Featuring Survival Questions and Answers

Introduction to Personalized Cancer Care

CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

REPORT. A Model Clinical Trials System for the 21st Century

Environments and Conditions that Facilitate Cardiac Arrest Research through Better Coordination, Oversight and Strategy.

Meltdown : Investing in Prevention. October 7, 2008

Delivering the best of both worlds effective, high-dose treatment with minimal side effects

Transforming cancer care: the bigger picture and what's next

Cancer Prevention & Control in Adolescent & Young Adult Survivors

An update on your support of the Kaplan Cancer Research Fund Swedish Cancer Institute

THE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director

Dr. Th. Leventouri. 777 Glades Road Boca Raton, FL Tel: Fax:

Oncology Drug Development Using Molecular Pathology

650, Our Failure to Deliver

Trends and disparities in cancer in Aotearoa/ NZ

A Golden Age of Drug Discovery in Cancer A Chat With Yujiro Hata, CEO of IDEAYA Biosciences

The Challenge of Accelerating Medical Solutions Through Philanthropy. Steve Case, Case Foundation Mike Milken, FasterCures

EARLY DETECTION: THE NEW CANCER PARADIGM

Cancer Institute. cancer institute Program overview Report 2013

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

BRP update from the NCI Acting Director

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research

Setting the scene Background of the Radiation Protection Culture initiative

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

Thomas C. Wilmot, Sr. Judy Wilmot Linehan

Overview of 2013 Hong Kong Cancer Statistics

Master of Science in Management: Fall 2018 and Spring 2019

Cancer Risk Factors in Ontario. Other Radiation

National Cancer Statistics in Korea, 2014

FIELD NOTES. Chris Anderson our Senior Editor gives a roundup of the recent developments in the precision medicine field.

Integrating Theory, Research, and Practice in Vocational Psychology: Perspectives of a Journal of Vocational Behavior Editorial Board Member

NCI Community Cancer Centers Program

NCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval

STANFORD CANCER CENTER. Clinical Studies. A Cancer Center Designated By The National Cancer Institute

MAKING INFORMED DECISIONS TO IMPROVE HEALTH CARE IN AMERICA. Harvey L. Neiman Health Policy Institute 2016 Year in Review

Transcription:

AAPM VISION Thoughts on the Future of Medical Physics Research in the New Era of Genomic Medicine John D. Hazle, Ph.D., FAAPM, FACR President American Association of Physicists in Medicine Professor and Chairman Department of Imaging Physics Bernard W. Biedenharn Chair in Cancer Research

My goal today was to convince you that wild physics should be promoted. It appears I m a little late!

AAPM characteristics and history Celebrating our 55 th anniversary this year Today is the International Day of Medical Physics Over 8,000 members from 25 countries 6,000 full members 70% radiation physics 25% imaging physics 5% other (hyperthermia, etc.) 85% some clinical responsibility 10% primarily research and education 5% government and industry 3

AAPM characteristics and history Prior to 1980, medical physics was a very academic discipline with most physicists working in larger institutions with some academic component. Surge in demand for clinical manpower beginning in the 1980 s resulted in the AAPM focus being driven by professional needs. Current definition of the Qualified Medical Physicist is an example of this effort. 4

AAPM characteristics and history Today, most research being carried out by AAPM members is translational or clinical and in the areas of radiation therapy and traditional radiological imaging technologies (including nuclear medicine). Science Council spends a lot of effort dedicated to the applications of physics principles in clinical practice (task group reports, reviewing position statements on the safe use of radiation, etc.) 5

What is medical physics? According to Wiki Medical Physics is generally speaking the application of physics concepts, theories and methods to medicine/healthcare. Biophysics is an interdisciplinary science that uses the methods of, and theories from physics to study biological systems. According to AAPM (from Vision statement) medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in biology and medicine. 6

Disruptive question for AAPM What other areas of medical physics science should the AAPM be promoting in the future?

What s driving cancer research? GOOD NEWS Death rates for the four most common cancers (prostate, breast, lung, colorectal), and all cancers combined, continue to decline. The rate of cancer incidence has declined since the early 2000s. Length of cancer survival has increased for all cancers combined. BAD NEWS Incidence rates of some cancers are rising including melanoma, non-hodgkin lymphoma, childhood cancer, leukemia, thyroid, pancreas, liver, testis. Death rates for pancreas, esophagus, thyroid, and liver are increasing. FACTS Cancer treatment spending continues to rise. Research funding is flat from all sources! Few cures

9

National Cancer Act of 1971 Signed into law by President Richard M. Nixon The act was created as a mechanism to make the elimination of cancer a national priority The press dubbed this the War on Cancer In 2003, NCI Director Andrew von Eschenbach issued a challenge to cure cancer by 2015 This position was supported by AACR in 2005 It s 2013 and we are not close to a cure!!! 10

11

12

Current funding priorities at NCI Much more impact focused. So it s a great idea. If it is successful, what will be the impact on patient mortality and morbidity? Instrumentation development will need a very well defined outlet. Difficult to get funding for platform technologies or incremental advances. Biology orientation For cancer, that s really genomics! 13

Human Genome Sequencing 14

Human Genome Project The project to sequence the human genome evolved from a DoE sponsored meeting in Santa Fe in 1986. Funding for the project was provided by the Reagan administration in 1987. In 1990, the DoE and NIH signed an MOU coordinating their funding efforts and set 1990 as the starting point of a 15 year clock. The project was declared complete in 2003. 99% of the genome was known to 99% accuracy 15

WHAT IS THE FUTURE OF MEDICAL PHYSICS RESEARCH IN A GENOMIC WORLD? 16

The omics of cancer 17

Hanahan & Weinberg, Cell 57-70, 2000

Hanahan & Weinberg, Cell 646-671, 2011

NCI provocative questions project How does obesity contribute to cancer risk? Are there ways to objectively ascertain exposure to cancer risk using modern measurement technologies? What are the molecular and cellular mechanisms by which patients with certain chronic diseases have increased or decreased risks for developing cancer, and can these connections be exploited to develop novel preventive or therapeutic strategies? Why do certain mutational events promote cancer phenotypes in some tissues and not in others? Can tumors be detected when they are two to three orders of magnitude smaller than those currently detected with in vivo imaging modalities? Are there definable properties of a non-malignant lesion that predict the likelihood of progression to invasive or metastatic disease?

Figure 14.3 The Biology of Cancer ( Garland Science 2007)

Figure 14.50a The Biology of Cancer ( Garland Science 2007)

Figure 10.5a The Biology of Cancer ( Garland Science 2007)

25

Small animal IGRT platforms Precision X-ray 225Cx Xstrahl SARRP

Linking hypoxia to malignant progression: hypoxia (Po2 1 mmhg) promotes genomic instability, thereby increasing the number of mutations (genetic variants). Padhani A R, Miles K A Radiology 2010;256:348-364 2010 by Radiological Society of North America

28

Figure 9.37 The Biology of Cancer ( Garland Science 2007)

How should AAPM move forward? Do we continue to focus in the sciences and practices of radiation physics, radiological imaging physics and nuclear medicine physics as they apply to humans? Do we expand the focus of AAPM to include a broader scope of science? What? Who? How? Work Group on the Future of Research and Education

My thoughts Some reasonably obvious opportunities. Quantitative imaging for therapy response assessment Functional (metabolic and physiologic) imaging to understand and sample tumor phenotype Participation in team science to solve the big problems of the future. We bring quantitative science skills that will enhance these teams. Organically develop new directions and scientific focus in areas of biomedical research expected to impact healthcare in the future. Partner with other organizations and groups to collectively advance the impact of medical physics research.

My thoughts This will require us to refine our educational programs to meet the scientific needs for future in research medical physics. Inclusion of non-traditional material in the curriculum of students intending to pursue a career in research. The AAPM s role is to provide a framework and infrastructure for addressing these challenges and opportunities, and to organize efforts to achieve our goals in research. Symposium at 2014 AAPM meeting on PSOC related research?

Imagination is more important than knowledge. Albert Einstein

The enemy is cancer, not another lab or institution. John Mendelsohn

38